Our new webinar series will be starting in October! Our Evonik health experts will be reviewing the latest formulation trends to develop supplements targeting cardiovascular and cognitive health.
Sign up to our free webinars below!
Have you got your head around anthocyanins, one of the most headline grabbing classes of active ingredients in the news today, as well as the innovations happening in the omega-3 market?
If not, then we have a free series of nutraceutical webinars this October that you can’t afford to miss.
The body of clinical evidence that supports the potential of these advanced food ingredients to improve or maintain cardiovascular and cognitive health is growing rapidly.
In response to growing consumer demand, a new generation of single and multi-ingredient combination products are now in development by nutraceutical companies. Many of these products are being tailored to address the health and lifestyle needs of specific consumer groups or application areas such as healthy ageing and pregnancy.
In this webinar series intended for B2B professionals within the nutraceutical industry, technical experts from Evonik Health Care will review the latest formulation trends and clinical data to bring you up to speed with the most recent, scientific evidence, and commercial opportunities.
This webinar series is intended for B2B professionals within the nutraceuticals industry only.
Thursday, October 1, 2020
10:00 a.m. (EDT) / 4:00 p.m. (CEST)
Anthocyanins, which are most concentrated in berries such as bilberries and blackcurrants, represent one of the most promising areas of nutritional research for cardiovascular health.
Their ability to have a potent and consistent effect on cholesterol levels, blood flow and platelet activity makes anthocyanins an attractive ingredient for use in dietary supplements and functional foods.
In addition to reviewing the latest clinical evidence on anthocyanins, this webinar will provide case studies on the use of one highly potent, naturally sourced health ingredient, and a final dosage form.
is a nutritional scientist at Evonik where she leverages her scientific and nutraceutical expertise to support the development of advanced food ingredients and co-ordinate related clinical trials.
Before joining Evonik in 2018, she was a registered dietitian and nutritional scientist for more than 13 years.
joined Evonik in 2019 as the director of consumer products for Evonik’s Health Care business line.
In her current role, she is responsible for Evonik’s nutraceutical brand MEDOX® and related consumer product business in German speaking countries.
Thursday, October 8, 2020
10:00 a.m. (EDT) / 4:00 p.m. (CEST)
The market for omega-3s is in a state of rapid transformation due to recent technology innovations and converging market trends. Clinical studies continue to highlight the benefits of omega-3 fatty acids for cardiovascular and cognitive health, as well as other areas including joint health and eye health.
In addition to recent improvements in the sustainability profile of omega-3s, it is now possible to select omega-3 grades that can match the dietary and lifestyle needs of specific target consumer groups.
This webinar will review the latest science on omega-3s for cardiovascular health as well as other health areas. Emerging opportunities to develop multi-ingredient combination products that can used with specific consumer groups or application areas, will also be reviewed, as well as the use of functional coatings with omega-3 supplements.
has been the director of new health ingredients at Evonik since 2017.
During that time, he has coordinated the development and commercial adoption of Evonik’s omega-3 platform across multiple international regions. In parallel, he has supported a number of nutraceutical companies to develop new formulations with omega-3 powder ingredients.
has been with Evonik since 2004. In 2014 she joined the Food Ingredients segment of Evonik Health Care. During that time, she has specialized in health ingredients and functional coatings for nutraceutical applications.